Unlocking Value Through Life Sciences Spin-offs and Carve-outs

Unlocking Value Through Life Sciences Spin-offs and Carve-outs

Webinar CLE

As life sciences and pharmaceutical companies continue to look for new ways to unlock additional value for stockholders, they are increasingly turning to spin-off and carve-out transactions. Please join members of WilmerHale’s Capital Markets, Mergers and Acquisitions, Licensing, and Tax groups for a lively and informative panel discussion of recent developments and trends in the area of spin-off and carve-out transactions. Our panelists will discuss different ways to create value through a spin-off or carve-out transaction, keys for successfully structuring and executing the deal, and important tax considerations.

View the Webinar Recording*

*CLE credit is not available for those who watch webinar recordings.

Read More About the Event



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.